Antibody-drug conjugates for urothelial carcinoma
Joseph Thomas, Michael Sun, Ted Getz, Benedict Ho, Jones T. Nauseef, Scott T. Tagawa
Topics & Concepts
MedicineOncologyPembrolizumabAntibody-drug conjugateInternal medicineImmunotherapyBladder cancerCancerCarcinomaEpidermal growth factor receptorAdverse effectAntibodyImmunologyMonoclonal antibodyBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesImmunotherapy and Immune Responses